Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             103 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormality of VTA local field potential in an animal model of depression was restored by patterned DBS treatment Friedman, Alexander
 2012
 22 Supplement 1 p. 64-71
8 p.
 artikel
2 Age, sex and NK1 receptors in the human brain — A positron emission tomography study with [11C]GR205171 Engman, Jonas
 2012
 22 Supplement 1 p. 562-568
7 p.
 artikel
3 Anhedonia and major depression: The role of agomelatine Di Giannantonio, Massimo
 2012
 22 Supplement 1 p. S505-S510
6 p.
 artikel
4 Association between the dexamethasone suppression test and serotonin transporter availability in healthy volunteers — A SPECT with [123I] ADAM study Tsai, Hsiang-Yi
 2012
 22 Supplement 1 p. 641-646
6 p.
 artikel
5 Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial Friedman, Edward S.
 2012
 22 Supplement 1 p. 183-199
17 p.
 artikel
6 C.08.03 Achieving effective symptom control and remission in bipolar I disorder McIntyre, R.
 2012
 22 Supplement 1 p. S447-S448
2 p.
 artikel
7 C.06.02 Can our patients do better? The relationship between motivational deficits and functional outcomes Foussias, G.
 2012
 22 Supplement 1 p. S446-S447
2 p.
 artikel
8 Changes in trend of antipsychotics prescription in patients treated with cholinesterase inhibitors after warnings from Italian Medicines Agency. Results from the EPIFARM-Elderly Project Franchi, Carlotta
 2012
 22 Supplement 1 p. 569-577
9 p.
 artikel
9 Clozapine resistance: Augmentation strategies Porcelli, Stefano
 2012
 22 Supplement 1 p. 165-182
18 p.
 artikel
10 Contents 2012
 22 Supplement 1 p. OBC-
1 p.
 artikel
11 Contents 2012
 22 Supplement 1 p. OBC-
1 p.
 artikel
12 C.02.03 Targeting cognitive and neuropsychiatric symptoms in early dementia Kasper, S.
 2012
 22 Supplement 1 p. S443-
1 p.
 artikel
13 Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR? Baldwin, David S.
 2012
 22 Supplement 1 p. 137-142
6 p.
 artikel
14 Early gene mapping after deep brain stimulation in a rat model of tardive dyskinesia: Comparison with transient local inactivation Creed, Meaghan C.
 2012
 22 Supplement 1 p. 506-517
12 p.
 artikel
15 ECNP Calendar of Events 2012
 22 Supplement 1 p. I-
1 p.
 artikel
16 Editorial Board 2012
 22 Supplement 1 p. IFC-
1 p.
 artikel
17 Editorial Board 2012
 22 Supplement 1 p. IFC-
1 p.
 artikel
18 Editorial Board 2012
 22 Supplement 1 p. IFC-
1 p.
 artikel
19 Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain Ghanbari, Ramez
 2012
 22 Supplement 1 p. 518-526
9 p.
 artikel
20 E.02.0 Setting the scene Courtet, P.
 2012
 22 Supplement 1 p. S149-
1 p.
 artikel
21 Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo Robson, Matthew J.
 2012
 22 Supplement 1 p. 308-317
10 p.
 artikel
22 Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses Arnone, D.
 2012
 22 Supplement 1 p. 1-16
16 p.
 artikel
23 Onset, time course and trajectories of improvement with antidepressants Lam, Raymond W.
 2012
 22 Supplement 1 p. S492-S498
7 p.
 artikel
24 P.1.a.008 CYP2D6 polymorphisms and dose of antidepressants in major depression: a naturalistic study Gressier, F.
 2012
 22 Supplement 1 p. S157-S158
2 p.
 artikel
25 P.3.a.012 Impact of improving negative symptoms on functioning in patients with schizophrenia: a post-hoc analysis of a proof-of-concept study Blattler, T.
 2012
 22 Supplement 1 p. S310-
1 p.
 artikel
26 P.1.a.005 Lithium-induced changes in circadian gene expression in lymphoblastoid cell lines of bipolar patients Kittel-Schneider, S.
 2012
 22 Supplement 1 p. S155-S156
2 p.
 artikel
27 P.2.a.008 Low serum allopregnanolone is associated with elevated depressive symptoms in late pregnancy Hellgren, C.
 2012
 22 Supplement 1 p. S228-
1 p.
 artikel
28 P.2.007 Alterations in nociceptive responding and prefrontal chemokine expression in a rat model of depression: effects of chronic amitriptyline Burke, N.N.
 2012
 22 Supplement 1 p. S37-S38
2 p.
 artikel
29 P.4.003 A neural cell adhesion molecule (NCAM)-derived peptide, FGL, counteracts serotonergic dysfunction in NCAM-deficient mice Aonurm-Helm, A.
 2012
 22 Supplement 1 p. S86-
1 p.
 artikel
30 P.4.a.011 Post-traumatic stress disorder and medical cannabis use: a naturalistic observational study Reznik, I.
 2012
 22 Supplement 1 p. S363-S364
2 p.
 artikel
31 P.5.a.003 Quality of life in mild cognitive impairment and mild Alzheimer's disease Shin, I.S.
 2012
 22 Supplement 1 p. S382-S383
2 p.
 artikel
32 P.7.a.005 Relationship of olfactory functions and psychopathology in patients with autism spectrum disorders Dudova, I.
 2012
 22 Supplement 1 p. S416-S417
2 p.
 artikel
33 P.2.a.025 Similar seizure characteristics of electroconvulsive therapy and magnetic seizure therapy in treatment-resistant depression Kayser, S.
 2012
 22 Supplement 1 p. S238-S239
2 p.
 artikel
34 P.1.023 Association between oxytocin receptor single nucleotide polymorphism rs2254298 and prepulse inhibition in healthy subjects Levin, R.
 2012
 22 Supplement 1 p. S23-S24
2 p.
 artikel
35 P.7.a.002 Treatment of psychiatric disorders in patients with tuberous sclerosis complex Jovic, N.
 2012
 22 Supplement 1 p. S414-S415
2 p.
 artikel
36 P.2.a.011 Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients Nivoli, A.M.A.
 2012
 22 Supplement 1 p. S230-
1 p.
 artikel
37 P.1.b.006 Cannabinoid CB2 receptor gene expression alterations in the dorsolateral prefrontal cortex and amygdala of suicide victims Garcia-Gutierrez, M.S.
 2012
 22 Supplement 1 p. S166-
1 p.
 artikel
38 P.2.b.013 Does the early response to deep brain stimulation in depression represent a placebo or electrode insertion effect? Perez-Caballero, L.
 2012
 22 Supplement 1 p. S248-S249
2 p.
 artikel
39 P.2.b.010 Effects of chronic mild stress and electroconvulsive seizure on memory functions in rats Wiborg, O.
 2012
 22 Supplement 1 p. S246-S247
2 p.
 artikel
40 P.6.b.005 Haplotype tag single-nucleotide polymorphism analysis of the vesicular glutamate transporter 2 gene in severe alcoholism among women Comasco, E.
 2012
 22 Supplement 1 p. S397-
1 p.
 artikel
41 P.7.b.004 Treatments for manic and mixed episodes of bipolar I disorder in children and adolescents: a systematic review Kusel, J.
 2012
 22 Supplement 1 p. S425-
1 p.
 artikel
42 P.2.010 Carbon dioxide-induced anxiety and the successive negative contrast effect in rats Mitchell, E.N.
 2012
 22 Supplement 1 p. S40-
1 p.
 artikel
43 P.1.c.017 A simple, reproducible and reliable method of gradual forced administration of psychotropic drugs in a drug dependence model in rats Lebedev, A.A.
 2012
 22 Supplement 1 p. S176-S177
2 p.
 artikel
44 P.3.c.007 Conventional antipsychotics versus atypical antipsychotics in elderly patients with psychiatric disorders Arnaoudova, M.
 2012
 22 Supplement 1 p. S320-S321
2 p.
 artikel
45 P.2.c.026 Early increase in the neuronal marker N-acetyl-aspartate with antidepressant treatment of major depression Taylor, M.J.
 2012
 22 Supplement 1 p. S265-
1 p.
 artikel
46 P.1.c.014 Etanercept effect on aortic nitric oxide dependent vasorelaxation in an unpredictable chronic mild stress model of depression in rats Bayramgurler, D.
 2012
 22 Supplement 1 p. S174-S175
2 p.
 artikel
47 P.1.c.013 Fluvoxamine alleviates endoplasmic reticulum stress via induction of Sigma-1 receptors Kudo, T.
 2012
 22 Supplement 1 p. S174-
1 p.
 artikel
48 P.3.c.045 Glycine augmentation of antipsychotic treatment may improve depressive symptomatology in schizophrenic patients Strzelecki, D.
 2012
 22 Supplement 1 p. S343-
1 p.
 artikel
49 P.3.c.031 Investigation of the applicability of a cybernetic model to clozapine-induced obsessive compulsive symptoms Shin, S.Y.
 2012
 22 Supplement 1 p. S334-S335
2 p.
 artikel
50 P.6.c.001 Legal and illegal substance consumption among Austrian students Zachbauer, C.
 2012
 22 Supplement 1 p. S398-S399
2 p.
 artikel
51 P.4.017 Cortisol decreases hippocampal neurogenesis by regulating the enzyme serum- and glucocorticoid-regulated kinase 1 Anacker, C.
 2012
 22 Supplement 1 p. S97-S98
2 p.
 artikel
52 P.2.c.012 Predictors of response and remission during an open-label, 10-week trial with selegiline transdermal system Portland, K.
 2012
 22 Supplement 1 p. S256-S257
2 p.
 artikel
53 P.3.c.027 The effect of antipsychotic drug treatment on serum levels of vascular endothelial growth factor (VEGF), sVEGFR-1, and sVEGFR-2 in schizophrenia Kim, D.H.
 2012
 22 Supplement 1 p. S332-S333
2 p.
 artikel
54 P.3.c.017 The effect of second generation antipsychotics on cognition in patients with early psychosis Montalvo, I.
 2012
 22 Supplement 1 p. S326-S327
2 p.
 artikel
55 P.3.c.004 The follow-up of akathisia and parkinsonian symptoms during the treatment of schizophrenia with olanzapine: a naturalistic study Krzystanek, M.
 2012
 22 Supplement 1 p. S318-S319
2 p.
 artikel
56 P.1.d.006 Aggravation of Toll-like receptor-4 (TLR4) mediated sickness behaviour by nucleotide-binding oligomerization domain-2 (NOD2) activation Farzi, A.
 2012
 22 Supplement 1 p. S185-
1 p.
 artikel
57 P.3.d.002 Association of RGS2 gene polymorphic loci with schizophrenia and the response to typical antipsychotics Gareeva, A.
 2012
 22 Supplement 1 p. S344-S345
2 p.
 artikel
58 P.4.014 Deep brain stimulation in treatment-resistant depression in mice Dournes, C.
 2012
 22 Supplement 1 p. S94-S95
2 p.
 artikel
59 P.6.d.003 Ethological evaluation of the effects of MDEA, a recreational drug similar to MDMA, on anxiety in the elevated maze in mice Muela, A.T.
 2012
 22 Supplement 1 p. S406-S407
2 p.
 artikel
60 P.4.d.001 Involvement of 5-HT1A receptors of the basolateral amygdala in the anxiolytic effect of chronic imipramine administration Vicente, M.
 2012
 22 Supplement 1 p. S372-
1 p.
 artikel
61 P.2.d.007 Presence of diurnal pattern of serum BDNF before partial sleep deprivation is associated with therapy response in major depression Giese, M.
 2012
 22 Supplement 1 p. S271-S272
2 p.
 artikel
62 P.2.d.010 The impact of co-treatment with antidepressants and memantine on immobility time in the tail suspension test; role of σ1 receptors Skuza, G.
 2012
 22 Supplement 1 p. S273-
1 p.
 artikel
63 P.7.e.001 Adult outcome of attention deficit hyperactivity disorder: a controlled 16-year follow-up study Biederman, J.
 2012
 22 Supplement 1 p. S435-
1 p.
 artikel
64 P.1.e.004 Brain serotonin neurotransmission and affect regulation in humans: a positron emission tomography study Selvaraj, S.
 2012
 22 Supplement 1 p. S193-S194
2 p.
 artikel
65 P.4.e.003 Brain structural correlates of dysfunctional beliefs in obsessive-compulsive disorder: role of the temporal pole Soriano-Mas, C.
 2012
 22 Supplement 1 p. S374-
1 p.
 artikel
66 P.1.e.007 Elevated prefrontal cortex monoamine oxidase-A binding in major depressive disorder and comorbid borderline personality disorder Kolla, N.
 2012
 22 Supplement 1 p. S195-S196
2 p.
 artikel
67 P.3.006 Effect of psychiatric co-morbidity and the method of insulin therapy on metabolic control in children with type 1 diabetes Butwicka, A.
 2012
 22 Supplement 1 p. S57-
1 p.
 artikel
68 P.2.e.027 Interleukin-6 as a biomarker of the model of staging in bipolar disorder Grande, I.
 2012
 22 Supplement 1 p. S291-S292
2 p.
 artikel
69 P.2.e.010 Observational, multinational study of bipolar I and II disorders (WAVE-bd): comparison of clinical data between France and other countries Bellivier, F.
 2012
 22 Supplement 1 p. S281-S282
2 p.
 artikel
70 Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life du Bois, Teresa Marie
 2012
 22 Supplement 1 p. 356-363
8 p.
 artikel
71 P.3.e.006 Sudden onset of psychosis as the sole manifestation of vitamin B12 deficiency Rodrigues, R.
 2012
 22 Supplement 1 p. S353-
1 p.
 artikel
72 P.5.e.004 Treatment of Alzheimer's disease: which effects on caregivers do we find? Riedel, O.
 2012
 22 Supplement 1 p. S388-S389
2 p.
 artikel
73 P.1.f.001 Early-life handling increases impulsive behaviours in adult life Kincheski, G.C.
 2012
 22 Supplement 1 p. S204-
1 p.
 artikel
74 P.2.g.008 Efficacy and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder Shin, D.
 2012
 22 Supplement 1 p. S300-
1 p.
 artikel
75 P.3.010 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3β increases the risk of suicidal behaviour in bipolar patients Jimenez, E.
 2012
 22 Supplement 1 p. S60-S61
2 p.
 artikel
76 P.1.g.010 Exploring effects of EAATs polymorphisms on cognitive functions in schizophrenia Spangaro, M.
 2012
 22 Supplement 1 p. S210-
1 p.
 artikel
77 P.2.g.011 The effects of acute psychopharmacological treatments on cognitive affective bias in rats Anderson, M.H.
 2012
 22 Supplement 1 p. S302-
1 p.
 artikel
78 P.1.009 Increased mRNA expression and release of neuropeptide S after REM sleep deprivation in rat Adori, C.
 2012
 22 Supplement 1 p. S10-S11
2 p.
 artikel
79 P.1.i.003 Predicting factors associated with drug compliance in psychiatric outpatients of a university hospital Bahk, W.
 2012
 22 Supplement 1 p. S220-
1 p.
 artikel
80 PL.06.01 Opioid systems: probing molecular processes of brain function Kieffer, B.L.
 2012
 22 Supplement 1 p. S111-S112
2 p.
 artikel
81 Polymorphisms in AKR1C4 and HSD3B2 and differences in serum DHEAS and progesterone are associated with paranoid ideation during mania or hypomania in bipolar disorder Johansson, Anette G.M.
 2012
 22 Supplement 1 p. 632-640
9 p.
 artikel
82 P.1.008 Recruitment of the mTOR complex 1 by 5-HT6 receptors: potential role in the cognitive deficits of schizophrenia Meffre, J.
 2012
 22 Supplement 1 p. S9-S10
2 p.
 artikel
83 P.1.006 Stimulation of D3 receptors activates Akt/GSK-3beta and mTOR signalling pathways in nucleus accumbens and striatum Salles, M.J.
 2012
 22 Supplement 1 p. S8-
1 p.
 artikel
84 P.3.003 The need for antidepressants in chronic haemodialysis Roventa, C.
 2012
 22 Supplement 1 p. S54-S55
2 p.
 artikel
85 P.3.020 The role of P-glycoprotein in central antihistamine effects Conen, S.
 2012
 22 Supplement 1 p. S69-
1 p.
 artikel
86 Reduced plasma levels of asymmetric Di-Methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal Frieling, Helge
 2012
 22 Supplement 1 p. 836-840
5 p.
 artikel
87 S.19.04 Arachidonic acid metabolism and neuroinflammation in bipolar disorder and its treatments Rapoport, S.I.
 2012
 22 Supplement 1 p. S137-
1 p.
 artikel
88 S.04.07 Cortisol decreases hippocampal neurogenesis by regulating the enzyme serum- and glucocorticoid-regulated kinase 1 Anacker, C.
 2012
 22 Supplement 1 p. S118-
1 p.
 artikel
89 S.07.04 Genetic variability at IMPA-2, INPP-1 and glycogen synthase kinase (GSK)-3β increases the risk of suicidal behaviour in bipolar patients Jimenez, E.
 2012
 22 Supplement 1 p. S122-
1 p.
 artikel
90 S.25.04 Immunotherapy in Alzheimer's disease – targeting toxic Aβ protofibrils Lannfelt, L.
 2012
 22 Supplement 1 p. S143-
1 p.
 artikel
91 S.13.02 Immunotherapy in tauopathies Sigurdsson, E.M.
 2012
 22 Supplement 1 p. S130-
1 p.
 artikel
92 S.08.04 MicroRNA in schizophrenia and developmental disorders Cairns, M.J.
 2012
 22 Supplement 1 p. S124-S125
2 p.
 artikel
93 S.05.02 Neurobiology Flügge, G.
 2012
 22 Supplement 1 p. S119-
1 p.
 artikel
94 S.04.02 Predictive animal models of depression Fuchs, E.
 2012
 22 Supplement 1 p. S82-S84
3 p.
 artikel
95 S.04.02 Recruitment of the mTOR complex 1 by 5-HT6 receptors: potential role in the cognitive deficits of schizophrenia Meffre, J.
 2012
 22 Supplement 1 p. S116-
1 p.
 artikel
96 S.14.01 The amygdala story in social anxiety disorder Iancu, I.
 2012
 22 Supplement 1 p. S131-
1 p.
 artikel
97 The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression Caraci, Filippo
 2012
 22 Supplement 1 p. 281-289
9 p.
 artikel
98 The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating Feifel, David
 2012
 22 Supplement 1 p. 374-378
5 p.
 artikel
99 The long-term abnormalities in circadian expression of Period 1 and Period 2 genes in response to stress is normalized by agomelatine administered immediately after exposure Koresh, Ori
 2012
 22 Supplement 1 p. 205-221
17 p.
 artikel
100 The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress Christensen, Jane H.
 2012
 22 Supplement 1 p. 651-656
6 p.
 artikel
101 Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats van de Giessen, Elsmarieke
 2012
 22 Supplement 1 p. 290-299
10 p.
 artikel
102 VEGF regulates antidepressant effects of lamotrigine Sun, Rongju
 2012
 22 Supplement 1 p. 424-430
7 p.
 artikel
103 Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles Kemp, David E.
 2012
 22 Supplement 1 p. 123-131
9 p.
 artikel
                             103 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland